Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study-Reference-Cited by-同舟云学术

Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study

Published:2021-10-08 Issue:11 Volume:14 Page:1021-1032
ISSN:1940-6207
Container-title:Cancer Prevention Research
language:en
Short-container-title:Cancer Prev Res

Author:

Furniss C. Sloane,Yurgelun Matthew B.^ORCID,Ukaegbu Chinedu,Constantinou Pamela E.,Lafferty Catherine C.,Talcove-Berko Eliana R.,Schwartz Alison N.,Stopfer Jill E.,Underhill-Blazey Meghan,Kenner Barbara,Nelson Scott H.,Okumura Sydney,Law Sherman,Zhou Alicia Y.,Coffin Tara B.,Rodriguez Nicolette J.,Uno Hajime^ORCID,Ocean Allyson J.,McAllister Florencia,Lowy Andrew M.^ORCID,Lippman Scott M.,Klein Alison P.^ORCID,Madlensky Lisa,Petersen Gloria M.,Garber Judy E.^ORCID,Goggins Michael G.,Maitra Anirban,Syngal Sapna^ORCID

Funder

Cancer-Lustgarten Foundation Pancreatic Cancer Interception Translational Cancer Research Grant

Entertainment Industry Foundation

American Association for Cancer Research

Mayo Clinic SPORE in Pancreatic Cancer

Khalifa Bin Zayed Foundation

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Access to Hereditary Testing in Pancreatic Ductal Carcinoma;JCO Precision Oncology;2024-08

2. Familial and hereditary pancreatic cancer in Japan;Familial Cancer;2024-05-11

3. Associations between subjective social status and predictors of interest in genetic testing among women diagnosed with breast cancer at a young age;Cancer Causes & Control;2024-05-03

4. A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study;Gastroenterology;2024-05

5. Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers;JCO Precision Oncology;2024-05